These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 10642089

  • 1. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats.
    Mizisin AP, Calcutt NA, Tomlinson DR, Gallagher A, Fernyhough P.
    J Peripher Nerv Syst; 1999; 4(3-4):211-21. PubMed ID: 10642089
    [Abstract] [Full Text] [Related]

  • 2. NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats.
    Mizisin AP, Kalichman MW, Bache M, Dines KC, DiStefano PS.
    J Neuropathol Exp Neurol; 1998 Sep; 57(9):803-13. PubMed ID: 9737543
    [Abstract] [Full Text] [Related]

  • 3. Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3.
    Middlemas A, Delcroix JD, Sayers NM, Tomlinson DR, Fernyhough P.
    Brain; 2003 Jul; 126(Pt 7):1671-82. PubMed ID: 12805110
    [Abstract] [Full Text] [Related]

  • 4. Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats.
    Weis J, Dimpfel W, Schröder JM.
    Muscle Nerve; 1995 Feb; 18(2):175-84. PubMed ID: 7823975
    [Abstract] [Full Text] [Related]

  • 5. Accelerated diabetic neuropathy in axons without neurofilaments.
    Zochodne DW, Sun HS, Cheng C, Eyer J.
    Brain; 2004 Oct; 127(Pt 10):2193-200. PubMed ID: 15289271
    [Abstract] [Full Text] [Related]

  • 6. Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats.
    Fernyhough P, Diemel LT, Tomlinson DR.
    Diabetologia; 1998 Mar; 41(3):300-6. PubMed ID: 9541170
    [Abstract] [Full Text] [Related]

  • 7. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
    Manschot SM, Gispen WH, Kappelle LJ, Biessels GJ.
    Diabetes Metab Res Rev; 2003 Mar; 19(6):469-77. PubMed ID: 14648806
    [Abstract] [Full Text] [Related]

  • 8. Functional and structural abnormalities in the nerves of type I diabetic baboons: aminoguanidine treatment does not improve nerve function.
    Birrell AM, Heffernan SJ, Ansselin AD, McLennan S, Church DK, Gillin AG, Yue DK.
    Diabetologia; 2000 Jan; 43(1):110-6. PubMed ID: 10672451
    [Abstract] [Full Text] [Related]

  • 9. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD, Davidovich A, Feldman D, Sprinkle TJ, Arezzo J, Brosnan C, Calderon RO, Fossom LH, DeVries JT, DeVries GH.
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [Abstract] [Full Text] [Related]

  • 10. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve.
    Lee PG, Hohman TC, Cai F, Regalia J, Helke CJ.
    Exp Neurol; 2001 Jul; 170(1):149-61. PubMed ID: 11421592
    [Abstract] [Full Text] [Related]

  • 11. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Biessels GJ, ter Laak MP, Kamal A, Gispen WH.
    Brain Res; 2005 Feb 21; 1035(1):86-93. PubMed ID: 15713280
    [Abstract] [Full Text] [Related]

  • 12. Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats.
    Sayers NM, Beswick LJ, Middlemas A, Calcutt NA, Mizisin AP, Tomlinson DR, Fernyhough P.
    Diabetes; 2003 Sep 21; 52(9):2372-80. PubMed ID: 12941778
    [Abstract] [Full Text] [Related]

  • 13. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA, Cameron NE, Hohman TC.
    J Peripher Nerv Syst; 1998 Sep 21; 3(3):217-23. PubMed ID: 10959252
    [Abstract] [Full Text] [Related]

  • 14. Anti-neurofilament antibodies in neuropathy with monoclonal gammopathy of undetermined significance produce experimental motor nerve conduction block.
    Stubbs EB, Lawlor MW, Richards MP, Siddiqui K, Fisher MA, Bhoopalam N, Siegel GJ.
    Acta Neuropathol; 2003 Feb 21; 105(2):109-16. PubMed ID: 12536221
    [Abstract] [Full Text] [Related]

  • 15. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy.
    Gao WQ, Dybdal N, Shinsky N, Murnane A, Schmelzer C, Siegel M, Keller G, Hefti F, Phillips HS, Winslow JW.
    Ann Neurol; 1995 Jul 21; 38(1):30-7. PubMed ID: 7611721
    [Abstract] [Full Text] [Related]

  • 16. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R, Sullivan KA, Van Huysen C, Bayer L, Cao X, Towns R, Stevens MJ.
    Exp Neurol; 2001 Apr 21; 168(2):259-72. PubMed ID: 11259114
    [Abstract] [Full Text] [Related]

  • 17. The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.
    Cameron NE, Cotter MA, Dines KC, Robertson S, Cox D.
    Br J Pharmacol; 1993 Aug 21; 109(4):972-9. PubMed ID: 8401950
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the effects of conventional insulin treatment and continuous insulin infusion therapy on established morphological and biochemical abnormalities of peripheral nerve in experimental diabetes.
    Britland S, Sharma A.
    Diabetes Res; 1990 Nov 21; 15(3):143-50. PubMed ID: 2132208
    [Abstract] [Full Text] [Related]

  • 19. Near nerve local insulin prevents conduction slowing in experimental diabetes.
    Singhal A, Cheng C, Sun H, Zochodne DW.
    Brain Res; 1997 Jul 25; 763(2):209-14. PubMed ID: 9296561
    [Abstract] [Full Text] [Related]

  • 20. Diabetes-induced alterations in calcium homeostasis in sensory neurones of streptozotocin-diabetic rats are restricted to lumbar ganglia and are prevented by neurotrophin-3.
    Huang TJ, Sayers NM, Fernyhough P, Verkhratsky A.
    Diabetologia; 2002 Apr 25; 45(4):560-70. PubMed ID: 12032634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.